Novozymes upgrades due to strong growth in bioenergy

Enzymes sales in particular experienced a rise at Novozymes, which is now upgrading its full-year guidance.

Photo: Novozymes

Novozymes achieved 4-percent organic growth in the first nine months of 2017 with 8-percent growth in the third quarter. Particularly enzymes for bioenergy performed well with growth of 10 percent.

This provided a result after tax of DKK 819 million (EUR 110 million), slightly more than analyst expectations of DKK 795 million.

Read the whole article

Get 14 days free access.

No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Further reading

Related articles

Latest News

See all jobs